跳至主導覽 跳至搜尋 跳過主要內容

The contribution of caveolin-1 genotype and phenotype to hepatocellular carcinoma

  • Chin Mu Hsu
  • , Mei Due Yang
  • , Chia Wen Tsai
  • , Chien Yi Ho
  • , Wen Shin Chang
  • , Sheng Chi Chang
  • , Long Bin Jeng
  • , Yuhsin Tsai
  • , Fuu Jen Tsai*
  • , Da Tian Bau
  • *此作品的通信作者
  • Graduate Institute of Clinical Medical Science
  • Departments of Medical Research and Internal Medicine
  • China Medical University Taichung

研究成果: 期刊稿件 › 文章 › 同儕審查

24 引文 斯高帕斯(Scopus)

摘要

Background: Hepatocellular carcinoma (HCC) is one of the most common types of malignant tumors worldwide, for which the prevalence and mortality rates are very high in Taiwan. Caveolin-1 (CAV-1) is a main structural protein of caveolae and plays a regulatory role in signaling pathways and tumorigenesis. High expression of Cav-1 in mouse HCC is positively correlated with higher cell invasive capacity, but the contribution of CAV-1 genetic variants during HCC progression is still largely unknown. In this study, we investigated the contribution of CAV-1 variant to the risk of HCC from the analyses of DNA, RNA and proteins. Materials and Methods: We enrolled 298 patients with HCC and 298 cancer-free controls, frequency-matched by age and gender in this case-control study. Firstly, the associations of six single nucleotide polymorphisms (SNPs) of the Cav-1 gene at C521A (rs1997623), G14713A (rs3807987), G21985A (12672038), T28608A (rs3757733), T29107A (rs7804372), and G32124A (rs3807992) with HCC risk in a Taiwanese population were evaluated. Secondly, thirty HCC tissue samples with variant genotypes were tested to estimate for CAV-1 mRNA expression by real-time quantitative reverse transcription. Finally, the HCC tissue samples of variant genotypes were examined by western blotting to estimate their CAV-1 protein expression patterns. Results: There were significant differences between the HCC and control groups in the distributions of the CAV-1 G14713A genotypes (p=0.0124), and these carrying AG and AA genotypes had a higher risk for HCC, compared with those with the GG genotype (odds ratio=1.51 and 1.94, respectively). Patients with CAV-1 G14713A AG or AA genotype had higher levels of mRNA (p=0.0001) and protein (p=0.0019) than those with the GG genotype. Conclusion: Our multi-approach findings at the DNA, RNA and protein levels suggest that CAV-1 may play a critical role in HCC carcinogenesis, and serve as a target for HCC therapy.

原文英語
頁(從 - 到)671-678
頁數8
期刊Anticancer Research
卷33
發行號2
出版品狀態已出版 - 02 2013
對外發佈是

UN SDG

此研究成果有助於以下永續發展目標

  1. SDG3 健康與福祉
    SDG3 健康與福祉

指紋

深入研究「The contribution of caveolin-1 genotype and phenotype to hepatocellular carcinoma」主題。共同形成了獨特的指紋。

引用此